Combination treatment for Netherton syndrome
AssigneeQuoin Pharmaceuticals, Inc.
InventorsMichael Myers, Denise Carter
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods of treating Netherton syndrome. In one embodiment, the method comprises administering to the patient (i) a serine protease inhibitor and (ii) an anti-inflammatory agent. In another embodiment, the method comprises (a) administering to the patient a serine protease inhibitor and an anti-inflammatory agent when the patient is having an outbreak of Netherton syndrome, and (b) administering a serine protease inhibitor when the patient is in remission. The present invention also relates to pharmaceutical compositions comprising (i) a serine protease inhibitor and (ii) an anti-inflammatory agent.
Claims10
A method of treating Netherton syndrome in a patient in need thereof comprising administering to the patient an effective amount of (i) a serine protease inhibitor and (ii) an anti-inflammatory agent, wherein the serine protease inhibitor is dipalmitoyl hydroxyproline or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.